This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Public Health Experts Address Bristol-Myers Squibb Foundation Together On Diabetes® Grantees And Applaud Collaborations Between Clinicians And Communities To Reduce Diabetes Disparities

Public health experts from the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Public Health Service applauded grantees of the Bristol-Myers Squibb Foundation and its Together on Diabetes ® initiative for their collaborative efforts to improve health outcomes and reduce disparities for people living with type 2 diabetes by strengthening patients’ ability to manage their own care with supportive community services.

During the two-day summit at Emory University, nonprofit grantees and their partners from across the United States joined diabetes experts from the U.S. government and various academic and public health institutions to discuss how communities can build, integrate and coordinate medical, non-medical and policy efforts, and expand the base of community organizations actively bringing their know-how, reach, influence and assets to the fight against type 2 diabetes.

CDC reports that 79 million Americans are pre-diabetic and at increased risk of developing type 2 diabetes in the next 10 years. About 1.9 million new cases of diabetes are diagnosed in people age 20 and older each year. If current trends persist, as many as one in three Americans will have diabetes by 2050, CDC projects.

Nearly half of all patients who have been diagnosed with type 2 diabetes do not have their disease adequately controlled through a combination of diet, physical activity and medication. Patients with uncontrolled type 2 diabetes face increased risk of complications such as cardiovascular disease, high blood pressure and stroke; damage to the nerves, eyes and kidneys; and amputation of the fingers, toes or limbs.

“While CDC has reported declining rates of some of the most serious complications of diabetes, including kidney failure, amputation of feet and legs, hospitalizations and vision loss, we are not seeing these drops in all groups,” said Ann Albright, Ph.D., R.D., director of CDC’s Division of Diabetes Translation, who addressed the summit Tuesday. “Improving access to health care, including teaching people how to care for themselves if they have diabetes, is so important. So is strong community support for healthy lifestyles.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs